{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:21:16Z","timestamp":1787023276411,"version":"build-2736575974"},"reference-count":42,"publisher":"Zhejiang University Press","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"DOI":"10.1631\/jzus.b2400345","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:31:43Z","timestamp":1765326703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19","\u4f4f\u9662 COVID-19 \u60a3\u8005\u5faa\u73af\u4e2d ACE2\u3001TLR4 \u548c IL-17 \u57fa\u56e0\u8868\u8fbe\u4e0e\u75be\u75c5\u4e25\u91cd\u7a0b\u5ea6\u53ca\u9884\u540e\u7684\u6f5c\u5728\u5173\u7cfb"],"prefix":"10.1631","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-5691","authenticated-orcid":false,"given":"Marwa A.","family":"Dahpy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragaa H.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Raheim M. A.","family":"Meki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf Zein","family":"El-Abedeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiada K.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtsam S.","family":"Abdulkareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Mohany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Djurasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal N.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhan M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shima Gafar","family":"Mansor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ramadan","family":"Izzaldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa K.","family":"Khairallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzan Eid Elshishtawy","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzahra","family":"Abdelbadea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam Khaled Ali","family":"Harby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Y. A.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa A.","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa Seif","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelraouf M. S.","family":"Abdelraouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"3","key":"814_CR1","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/microorganisms11030612","volume":"11","author":"S Alabsi","year":"2023","unstructured":"Alabsi S, Dhole A, Hozayen S, et al., 2023. Angiotensin-converting enzyme 2 expression and severity of SARS-CoV-2 infection. Microorganisms, 11(3):612. https:\/\/doi.org\/10.3390\/microorganisms11030612","journal-title":"Microorganisms"},{"issue":"1","key":"814_CR2","doi-asserted-by":"publisher","first-page":"e12653","DOI":"10.1016\/j.heliyon.2022.e12653","volume":"9","author":"W Alturaiki","year":"2023","unstructured":"Alturaiki W, Alkadi H, Alamri S, et al., 2023. Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity. Heliyon, 9(1):e12653. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12653","journal-title":"Heliyon"},{"issue":"1","key":"814_CR3","doi-asserted-by":"publisher","first-page":"e28205","DOI":"10.1002\/jmv.28205","volume":"95","author":"SL Au Yeung","year":"2023","unstructured":"Au Yeung SL, Wong THT, He BT, et al., 2023. Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: a Mendelian randomization investigation. J Med Virol, 95(1):e28205. https:\/\/doi.org\/10.1002\/jmv.28205","journal-title":"J Med Virol"},{"issue":"4","key":"814_CR4","doi-asserted-by":"publisher","first-page":"e13715","DOI":"10.1111\/dth.13715","volume":"33","author":"E Ayhan","year":"2020","unstructured":"Ayhan E, \u00d6zt\u00fcrk M, An \u0130, et al., 2020. Potential role of anti-interleukin-17 in COVID-19 treatment. Dermatol Ther, 33(4):e13715. https:\/\/doi.org\/10.1111\/dth.13715","journal-title":"Dermatol Ther"},{"issue":"7","key":"814_CR5","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1111\/all.14364","volume":"75","author":"AK Azkur","year":"2020","unstructured":"Azkur AK, Akdis M, Azkur D, et al., 2020. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy, 75(7):1564\u20131581. https:\/\/doi.org\/10.1111\/all.14364","journal-title":"Allergy"},{"key":"814_CR6","doi-asserted-by":"publisher","first-page":"103804","DOI":"10.1016\/j.resp.2021.103804","volume":"296","author":"E Bartol\u00e1k-Suki","year":"2022","unstructured":"Bartol\u00e1k-Suki E, Mondo\u00f1edo JR, Suki B, 2022. Mechanoinflammatory sensitivity of ACE2: implications for the regional distribution of SARS-CoV-2 injury in the lung. Respir Physiol Neurobiol, 296:103804. https:\/\/doi.org\/10.1016\/j.resp.2021.103804","journal-title":"Respir Physiol Neurobiol"},{"key":"814_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.cytogfr.2020.09.002","volume":"58","author":"SCS Brand\u00e3o","year":"2021","unstructured":"Brand\u00e3o SCS, de Oliveira Xavier Ramos J, Dompieri LT, et al., 2021. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities? Cytokine Growth Factor Rev, 58:102\u2013110. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.09.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"814_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11882-022-01059-6","volume":"23","author":"J Chee","year":"2023","unstructured":"Chee J, Chern B, Loh WS, et al., 2023. Pathophysiology of SARS-CoV-2 infection of nasal respiratory and olfactory epithelia and its clinical impact. Curr Allergy Asthma Rep, 23(2):121\u2013131. https:\/\/doi.org\/10.1007\/s11882-022-01059-6","journal-title":"Curr Allergy Asthma Rep"},{"issue":"10","key":"814_CR9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/jmv.25987","volume":"92","author":"A Choudhury","year":"2020","unstructured":"Choudhury A, Mukherjee S, 2020. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs. J Med Virol, 92(10):2105\u20132113. https:\/\/doi.org\/10.1002\/jmv.25987","journal-title":"J Med Virol"},{"issue":"12","key":"814_CR10","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1002\/ptr.7302","volume":"35","author":"C Corpetti","year":"2021","unstructured":"Corpetti C, Del Re A, Seguella L, et al., 2021. Cannabidiol inhibits SARS-Cov-2 spike (S) protein-induced cytotoxicity and inflammation through a PPAR\u03b3-dependent TLR4\/NLRP3\/Caspase-1 signaling suppression in Caco-2 cell line. Phytother Res, 35(12):6893\u20136903. https:\/\/doi.org\/10.1002\/ptr.7302","journal-title":"Phytother Res"},{"key":"814_CR11","doi-asserted-by":"publisher","first-page":"104799","DOI":"10.1016\/j.micpath.2021.104799","volume":"153","author":"D Darif","year":"2021","unstructured":"Darif D, Hammi I, Kihel A, et al., 2021. The pro-inflammatory cytokines in COVID-19 pathogenesis: what goes wrong? Microb Pathog, 153:104799. https:\/\/doi.org\/10.1016\/j.micpath.2021.104799","journal-title":"Microb Pathog"},{"issue":"4","key":"814_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/jcm12041323","volume":"12","author":"S del Carmen Ch\u00e1vez-Oca\u00f1a","year":"2023","unstructured":"del Carmen Ch\u00e1vez-Oca\u00f1a S, Bravata-Alc\u00e1ntara JC, Cort\u00e9s-Ortiz IA, et al., 2023. Parameters to predict the outcome of severe and critical COVID-19 patients when admitted to the hospital. J Clin Med, 12(4):1323. https:\/\/doi.org\/10.3390\/jcm12041323","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"814_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00109-023-02283-x","volume":"101","author":"GP Dorneles","year":"2023","unstructured":"Dorneles GP, Teixeira PC, Peres A, et al., 2023. Endotoxin tolerance and low activation of TLR-4\/NF-\u03baB axis in monocytes of COVID-19 patients. J Mol Med, 101(1\u20132):183\u2013195. https:\/\/doi.org\/10.1007\/s00109-023-02283-x","journal-title":"J Mol Med"},{"issue":"6","key":"814_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","volume":"80","author":"LW Fu","year":"2020","unstructured":"Fu LW, Wang BY, Yuan TW, et al., 2020. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. J Infect, 80(6):656\u2013665. https:\/\/doi.org\/10.1016\/j.jinf.2020.03.041","journal-title":"J Infect"},{"key":"814_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40560-023-00658-3","volume":"11","author":"S Fujishima","year":"2023","unstructured":"Fujishima S, 2023. Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. J Intensive Care, 11:10. https:\/\/doi.org\/10.1186\/s40560-023-00658-3","journal-title":"J Intensive Care"},{"issue":"3","key":"814_CR16","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3390\/ijms22030992","volume":"22","author":"LK Gadanec","year":"2021","unstructured":"Gadanec LK, McSweeney KR, Qaradakhi T, et al., 2021. Can SARS-CoV-2 virus use multiple receptors to enter host cells? Int J Mol Sci, 22(3):992. https:\/\/doi.org\/10.3390\/ijms22030992","journal-title":"Int J Mol Sci"},{"key":"814_CR17","doi-asserted-by":"publisher","first-page":"155323","DOI":"10.1016\/j.cyto.2020.155323","volume":"137","author":"A Ghazavi","year":"2021","unstructured":"Ghazavi A, Ganji A, Keshavarzian N, et al., 2021. Cytokine profile and disease severity in patients with COVID-19. Cytokine, 137:155323. https:\/\/doi.org\/10.1016\/j.cyto.2020.155323","journal-title":"Cytokine"},{"issue":"1","key":"814_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"BY Hu","year":"2021","unstructured":"Hu BY, Huang SY, Yin LH, 2021. The cytokine storm and COVID-19. J Med Virol, 93(1):250\u2013256. https:\/\/doi.org\/10.1002\/jmv.26232","journal-title":"J Med Virol"},{"key":"814_CR19","doi-asserted-by":"publisher","first-page":"114738","DOI":"10.1016\/j.jep.2021.114738","volume":"283","author":"SP Jose","year":"2022","unstructured":"Jose SP, Ratheesh M, Sheethal S, et al., 2022. Anti-inflammatory effect of Kaba Sura Kudineer (AYUSH approved COVID-19 drug)-A Siddha poly-herbal formulation against lipopolysaccharide induced inflammatory response in RAW-264.7 macrophages cells. J Ethnopharmacol, 283:114738. https:\/\/doi.org\/10.1016\/j.jep.2021.114738","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"814_CR20","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1002\/jmv.26826","volume":"93","author":"S Khanmohammadi","year":"2021","unstructured":"Khanmohammadi S, Rezaei N, 2021. Role of Toll-like receptors in the pathogenesis of COVID-19. J Med Virol, 93(5):2735\u20132739. https:\/\/doi.org\/10.1002\/jmv.26826","journal-title":"J Med Virol"},{"key":"814_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13000-022-01207-6","volume":"17","author":"E Kogan","year":"2022","unstructured":"Kogan E, Berezovskiy Y, Blagova O, et al., 2022. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn Pathol, 17:31. https:\/\/doi.org\/10.1186\/s13000-022-01207-6","journal-title":"Diagn Pathol"},{"issue":"4","key":"814_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/vaccines5040034","volume":"5","author":"NN Kuzmich","year":"2017","unstructured":"Kuzmich NN, Sivak KV, Chubarev VN, et al., 2017. TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis. Vaccines, 5(4):34. https:\/\/doi.org\/10.3390\/vaccines5040034","journal-title":"Vaccines"},{"issue":"6","key":"814_CR23","doi-asserted-by":"publisher","first-page":"2000562","DOI":"10.1183\/13993003.00562-2020","volume":"55","author":"WH Liang","year":"2020","unstructured":"Liang WH, Guan WJ, Li CC, et al., 2020. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J, 55(6):2000562. https:\/\/doi.org\/10.1183\/13993003.00562-2020","journal-title":"Eur Respir J"},{"key":"814_CR24","doi-asserted-by":"publisher","first-page":"113788","DOI":"10.1016\/j.bios.2021.113788","volume":"198","author":"S Liu","year":"2022","unstructured":"Liu S, Han LP, Li JL, et al., 2022. Electrochemical detection of ACE2 as a biomarker for diagnosis of COVID-19 and potential male infertility. Biosens Bioelectron, 198:113788. https:\/\/doi.org\/10.1016\/j.bios.2021.113788","journal-title":"Biosens Bioelectron"},{"key":"814_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2017.06.035","volume":"90","author":"M Luo","year":"2017","unstructured":"Luo M, Hu LJ, Li DD, et al., 2017. MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88\/NF-\u03baB-dependent pathway in alveolar macrophages cell line. Mol Immunol, 90:1\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2017.06.035","journal-title":"Mol Immunol"},{"issue":"3","key":"814_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1002\/jmv.27405","volume":"94","author":"M Manik","year":"2022","unstructured":"Manik M, Singh RK, 2022. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19. J Med Vorol, 94(3):869\u2013877. https:\/\/doi.org\/10.1002\/jmv.27405","journal-title":"J Med Vorol"},{"key":"814_CR27","doi-asserted-by":"publisher","first-page":"109749","DOI":"10.1016\/j.mehy.2020.109749","volume":"140","author":"M Megna","year":"2020","unstructured":"Megna M, Napolitano M, Fabbrocini G, 2020. May IL-17 have a role in COVID-19 infection? Med Hypothese, 140:109749. https:\/\/doi.org\/10.1016\/j.mehy.2020.109749","journal-title":"Med Hypothese"},{"key":"814_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, et al., 2022. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J, 19:92. https:\/\/doi.org\/10.1186\/s12985-022-01814-1","journal-title":"Virol J"},{"issue":"4","key":"814_CR29","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s12598-021-01894-y","volume":"41","author":"YQ Ni","year":"2022","unstructured":"Ni YQ, Zeng HH, Song XW, et al., 2022. Potential metal-related strategies for prevention and treatment of COVID-19. Rare Met, 41(4):1129\u20131141. https:\/\/doi.org\/10.1007\/s12598-021-01894-y","journal-title":"Rare Met"},{"issue":"5","key":"814_CR30","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2023.01.039","volume":"186","author":"GY Oudit","year":"2023","unstructured":"Oudit GY, Wang KM, Viveiros A, et al., 2023. Angiotensinconverting enzyme 2\u2014at the heart of the COVID-19 pandemic. Cell, 186(5):906\u2013922. https:\/\/doi.org\/10.1016\/j.cell.2023.01.039","journal-title":"Cell"},{"issue":"6","key":"814_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3855\/jidc.17762","volume":"17","author":"Y Pan","year":"2023","unstructured":"Pan Y, 2023. Angiotensin-converting enzyme 2 G8790A polymorphisms are associated with COVID-19 severity. J Infect Dev Ctries, 17(6):819\u2013825. https:\/\/doi.org\/10.3855\/jidc.17762","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"814_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.13091","volume":"288","author":"G Pascarella","year":"2020","unstructured":"Pascarella G, Strumia A, Piliego C, et al., 2020. COVID-19 diagnosis and management: a comprehensive review. J Intern Med, 288(2):192\u2013206. https:\/\/doi.org\/10.1111\/joim.13091","journal-title":"J Intern Med"},{"issue":"12","key":"814_CR33","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.3390\/v13122537","volume":"13","author":"M Rahman","year":"2021","unstructured":"Rahman M, Irmler M, Keshavan S, et al., 2021. Differential effect of SARS-CoV-2 spike glycoprotein 1 on human bronchial and alveolar lung mucosa models: implications for pathogenicity. Viruses, 13(12):2537. https:\/\/doi.org\/10.3390\/v13122537","journal-title":"Viruses"},{"issue":"3","key":"814_CR34","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.3390\/cimb45030128","volume":"45","author":"S S\u00e1nchez-D\u00edez","year":"2023","unstructured":"S\u00e1nchez-D\u00edez S, G\u00f3mez-Oll\u00e9s C, Cruz MJ, et al., 2023. Biomarker profiles associated with COVID-19 severity and mortality. Curr Issues Mol Biol, 45(3):1998\u20132012. https:\/\/doi.org\/10.3390\/cimb45030128","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"814_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/vaccines11010013","volume":"11","author":"PV Sodhi","year":"2023","unstructured":"Sodhi PV, Sidime F, Tarazona DD, et al., 2023. A closer look at ACE2 signaling pathway and processing during COVID-19 infection: identifying possible targets. Vaccines, 11(1):13. https:\/\/doi.org\/10.3390\/vaccines11010013","journal-title":"Vaccines"},{"issue":"38","key":"814_CR36","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.3346\/jkms.2020.35.e343","volume":"35","author":"KM Sohn","year":"2020","unstructured":"Sohn KM, Lee SG, Kim HJ, et al., 2020. COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis. J Korean Med Sci, 35(38):e343. https:\/\/doi.org\/10.3346\/jkms.2020.35.e343","journal-title":"J Korean Med Sci"},{"issue":"7","key":"814_CR37","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3390\/vaccines10071045","volume":"10","author":"RH Sultan","year":"2022","unstructured":"Sultan RH, Abdallah M, Ali TM, et al., 2022. The associations between cytokine levels, kidney and heart function biomarkers, and expression levels of angiotensin-converting enzyme-2 and neuropilin-1 in COVID-19 patients. Vaccines, 10(7):1045. https:\/\/doi.org\/10.3390\/vaccines10071045","journal-title":"Vaccines"},{"key":"814_CR38","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.2147\/JIR.S343246","volume":"14","author":"SI Taha","year":"2021","unstructured":"Taha SI, Shata AK, Baioumy SA, et al., 2021. Toll-like receptor 4 polymorphisms (896A\/G and 1196C\/T) as an indicator of COVID-19 severity in a convenience sample of Egyptian patients. J Inflamm Res, 14:6293\u20136303. https:\/\/doi.org\/10.2147\/jir.s343246","journal-title":"J Inflamm Res"},{"key":"814_CR39","volume-title":"Pandemic Influenza Severity Assessment (PISA): A WHO guide to assess the severity of influenza epidemics and pandemics","author":"World Health Organization","year":"2020","unstructured":"World Health Organization, 2020. Pandemic Influenza Severity Assessment (PISA): A WHO guide to assess the severity of influenza epidemics and pandemics. World Health Organization, Geneva. https:\/\/www.who.int\/news\/item\/05-07-2024-pandemic-and-seasonal-influenza-severity-assessment-guidance-updated"},{"issue":"2","key":"814_CR40","doi-asserted-by":"publisher","first-page":"e00402-22","DOI":"10.1128\/mbio.00402-22","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Xia T, Shin WJ, et al., 2022. Viral mimicry of interleukin-17A by SARS-CoV-2 ORF8. mBio, 13(2):e00402-22. https:\/\/doi.org\/10.1128\/mbio.00402-22","journal-title":"mBio"},{"issue":"4","key":"814_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang YJ, et al., 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med, 8(4):420\u2013422. https:\/\/doi.org\/10.1016\/s2213-2600(20)30076-x","journal-title":"Lancet Respir Med"},{"issue":"2","key":"814_CR42","doi-asserted-by":"publisher","first-page":"360","DOI":"10.14336\/AD.2021.0805","volume":"13","author":"M Zheng","year":"2022","unstructured":"Zheng M, 2022. ACE2 and COVID-19 susceptibility and severity. Aging Dis, 13(2):360\u2013372. https:\/\/doi.org\/10.14336\/ad.2021.0805","journal-title":"Aging Dis"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2400345\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:01:51Z","timestamp":1765332111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2400345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":42,"alternative-id":["814"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2400345","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Marwa A. DAHPY, Ragaa H. SALAMA, Abdel-Raheim M. A. MEKI, Ashraf Zein El-ABEDEEN, Maiada K. HASHEM, Ebtsam S. ABDULKAREEM, Mohamed MOHANY, Sinisa DJURASEVIC, Amal N. IBRAHIM, Nourhan M. HUSSEIN, Shima Gafar MANSOR, Mohamed Ramadan IZZALDIN, Marwa K. KHAIRALLAH, Suzan Eid Elshishtawy IBRAHIM, Alzahra ABDELBADEA, Islam Khaled Ali HARBY, Fatma Y. A. ABBAS, Rasha M. ALI, Marwa A. SABET, Salwa Seif ElDIN, Abdelraouf M. S. ABDELRAOUF, and Amira A. KAMEL declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The ethical committee of Faculty of Medicine, Assiut University has reviewed and approved the study (IRB No. 17101957), with date of original approval 2022. Before participation in the trial, informed consent was acquired from every patient and control subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}